Brief: Rubius Therapeutics Reports Q1 Loss Per Share $0.42

Rubius Therapeutics

15/05/2019 13:09

May 15 (Reuters) - Rubius Therapeutics Inc  RUBY.O :
    * RUBIUS THERAPEUTICS REPORTS FIRST QUARTER 2019 FINANCIAL
RESULTS
AND OPERATIONAL PROGRESS
    * Q1 LOSS PER SHARE $0.42
    * Q1 EARNINGS PER SHARE ESTIMATE $-0.38 -- REFINITIV IBES
DATA
    * RUBIUS THERAPEUTICS - AS OF MARCH 31, CASH EQUIVALENTS AND
INVESTMENTS WERE $378.9 MILLION AS COMPARED TO $404.1 MILLION AS
OF DECEMBER 31, 2018
    * CASH, CASH EQUIVALENTS AND INVESTMENTS PROVIDE RUBIUS WITH
A
CASH RUNWAY INTO 2021

Source text for Eikon:  ID:nGNX4JKs92 
Further company coverage:  RUBY.O 

 ((Briefs@thomsonreuters.com;))